Captor Therapeutics ® Investor Relations

      Investor Relations

      Announcement of convening Extraordinary General Meeting together with draft resolutions

      Publication date: 2022-01-25
      Number: RB ESPI 4/2022

      Current Report No. 4/2022

      Date of preparation: 25 January 2022

      Subject: Announcement of convening Extraordinary General Meeting together with draft resolutions

      Legal basis: Art. 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company"), pursuant to Article 398, Article 399 § 2 in connection with Article 402¹ and 402² of the Code of Commercial Companies, informs that the Supervisory Board of the Company convened for 21 February 2022 Extraordinary General Meeting of the Company, which will be held at 2:00 p.m. in Wrocław, 125 Klecińska, Beta building.

      The full text of the announcement together with the agenda of the Extraordinary General Meeting is enclosed. Enclosed are also draft resolutions.

      The Company's Supervisory Board convened the Extraordinary General Meeting under § 25 section 6 of the Company's Articles of Association, according to which the Company's Supervisory Board convenes the General Meeting in order to approve the co-optation of a member of the Company's Supervisory Board.


      Attachments: